HomeCompareLEXXW vs PEP

LEXXW vs PEP: Dividend Comparison 2026

LEXXW yields 166666.67% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LEXXW wins by $7.944525992890705e+28M in total portfolio value
10 years
LEXXW
LEXXW
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full LEXXW calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — LEXXW vs PEP

📍 LEXXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLEXXWPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LEXXW + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LEXXW pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEXXW
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, LEXXW beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEXXW + PEP for your $10,000?

LEXXW: 50%PEP: 50%
100% PEP50/50100% LEXXW
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

LEXXW
No analyst data
Altman Z
-20.1
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEXXW buys
0
PEP buys
6
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$PEP▼ Sell$1,001 - $15,0002026-02-23
Sheldon Whitehouse🏛 Senate$PEP▼ Sell$1,001 - $15,0002026-02-23
Julia Letlow🏢 House$PEP▲ Buy$1,001 - $15,0002026-02-05
Julie Johnson🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-18
Jared Moskowitz🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-02
Jared Moskowitz🏢 House$PEP▼ Sell$1,001 - $15,0002025-12-02
Jared Moskowitz🏢 House$PEP▼ Sell$15,001 - $50,0002025-12-02
Julie Johnson🏢 House$PEP▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$PEP▲ Buy$1,001 - $15,0002025-11-05
Scott DesJarlais🏢 House$PEP▼ Sell$1,001 - $15,0002025-10-28
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLEXXWPEP
Forward yield166666.67%3.66%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$7.944525992890705e+28M$144.7K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$63,430.49
Total dividends collected$7.943912645651793e+28M$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LEXXW vs PEP ($10,000, DRIP)

YearLEXXW PortfolioLEXXW Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$16,677,367$16,666,666.67$10,854$514.44+$16.67MLEXXW
2$25,995,051,428$25,977,206,645.90$11,982$758.21+$25995.04MLEXXW
3$37,869,622,473,147$37,841,807,768,118.86$13,526$1,136.44+$37869622.46MLEXXW
4$51,562,007,868,526,340$51,521,487,372,480,070.00$15,727$1,741.93+$51562007868.51MLEXXW
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$19,012$2,750.28+$65615852892511.91MLEXXW
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$24,173$4,514.44+$78042202741585760.00MLEXXW
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$32,789$7,793.80+$86754863367545782272.00MLEXXW
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$48,258$14,354.51+$9.01371089860901e+22MLEXXW
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$78,586$28,686.63+$8.753081018840772e+25MLEXXW
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$144,688$63,430.49+$7.944525992890705e+28MLEXXW

LEXXW vs PEP: Complete Analysis 2026

LEXXWStock

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Full LEXXW Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this LEXXW vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEXXW vs SCHDLEXXW vs JEPILEXXW vs OLEXXW vs KOLEXXW vs MAINLEXXW vs MOLEXXW vs PMLEXXW vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.